Therapeutic interventions for heart failure in Colombia: result of a Delphi panel

Clímaco de Jesús Pérez Molina1,2,3, Carlos Castañeda Orjuela4, Pedro Valbuena Hernandez5

  • 1Department of Cardiology, Clinic of The Universidad de la Sabana, Bogotá, Colombia.

Plos One
|September 3, 2024
PubMed

Insights

Colombian cardiology experts reached a consensus on nine key therapies for heart failure (HF) treatment. These validated interventions aim to improve patient outcomes and optimize HF care in Colombia.

Area of Science:

  • Cardiology
  • Clinical Medicine

Background:

  • Heart failure (HF) management requires validated therapeutic strategies.
  • Establishing expert consensus is crucial for guideline development.

Purpose of the Study:

  • To validate primary heart failure therapies through expert consensus in Colombia.
  • To identify key interventions for optimizing HF treatment.

Main Methods:

  • Delphi technique utilized with Colombian cardiology experts.
  • Electronic questionnaires assessed relevance of therapeutic interventions.
  • Consensus defined by ≥70% expert agreement.

Main Results:

  • Fourteen cardiologists participated in multiple consensus rounds.
  • Consensus reached on eight therapeutic interventions after the second round.
  • Nine key therapeutic interventions for heart failure were ultimately identified.

Conclusions:

  • Clinical consensus achieved on nine relevant heart failure therapeutic interventions in Colombia.
  • Findings support improved HF treatment strategies and clinical outcomes.
  • Results reflect local expert opinion and may not be universally generalizable.
Abstract

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
404
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
352
Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
545
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
322
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
187